Matthew W. Foehr - 28 May 2021 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Role: President and COO
Signature: By: Charles S. Berkman For: Matthew W. Foehr
Issuer symbol: LGND
Transactions as of: 28 May 2021
Net transactions value: +$98,736
Form type: 4
Filing time: 01 Jun 2021, 16:59:32 UTC
Next filing: 10 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LGND	Common Stock	Gift	$0	-2,500	-1.5%	$0.000000	162,600	28 May 2021	Direct	F1
transaction	LGND	Common Stock	Options Exercise	$98,736	+1,755	+1.1%	$56.26	164,355	28 May 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LGND	Employee Stock Option (right to buy)	Options Exercise	$0	-1,755	-4.2%	$0.000000	40,358	28 May 2021	Common Stock	1,755	$56.26	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Charitable gift to a third party.
F2	Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant was 02/10/15.